Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025;28(9):1212-1219.
doi: 10.22038/ijbms.2025.86093.18615.

Intrathecal injections of non-peptide oxytocin receptor agonists, WAY 267,464 and TC OT 39, induce significant anti-hyperalgesia in both male and female rats with inflammatory pain

Lok-Hi Chow  1   2   3   4 , Yuan-Hao Chen  5 , Ying-Jie Chen  4 , Pin-Chen Lin  4 , Eagle Yi-Kung Huang  4
Affiliations

Intrathecal injections of non-peptide oxytocin receptor agonists, WAY 267,464 and TC OT 39, induce significant anti-hyperalgesia in both male and female rats with inflammatory pain

Lok-Hi Chow et al. Iran J Basic Med Sci. 2025.

Abstract

Objectives: Hyperalgesia is a clinical condition related to chronic pain in which patients experience increased nociceptive sensitivity. Intrathecal oxytocin has been shown to induce significant anti-hyperalgesia in both rodents and humans. However, in our previous studies, we demonstrated a clear sex difference in oxytocin's effects at the spinal level in rodents. We suggested that this sex difference could be partially due to the higher expression of the oxytocin-degrading enzyme, insulin-regulated aminopeptidase (IRAP), in the spinal cord of females. Thus, we aimed to evaluate non-peptide oxytocin receptor (OTR) agonists, which we speculated could effectively reduce inflammatory hyperalgesia in both sexes due to their resistance to IRAP degradation.

Materials and methods: Plantar tests were conducted on adult S.D. rats of both sexes to examine intraplantar carrageenan-induced hyperalgesia. This was followed by an intrathecal (i.t.) injection of non-peptide OTR agonists, WAY 267,464 and TC OT 39, to assess their effects on hyperalgesia. Atosiban, an OTR antagonist, was also co-administered with these compounds to confirm their involvement in OTR activation.

Results: WAY 267,464 and TC OT 39 were both effective in ameliorating anti-hyperalgesia in male and female rats, suggesting no sex difference. Additionally, atosiban attenuated the anti-hyperalgesia effects of WAY 267,464 and TC OT 39, confirming these compounds' involvement in OTR activation.

Conclusion: These compounds induced significant anti-hyperalgesia without any sex differences, suggesting that the inhibition of IRAP degradation eliminated the variation in oxytocin's effects based on sex. Therefore, we propose these compounds as promising candidates for treating inflammatory hyperalgesia in clinical applications.

Keywords: Hyperalgesia; Insulin-regulated- aminopeptidase; Oxytocin; Oxytocin receptor; Sex difference.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Effects of intrathecally injected WAY 267,464 on thermal hyperalgesia induced by intraplantar carrageenan injections in male rats
Figure 2
Figure 2
Effects of intrathecally injected WAY 267,464 on thermal hyperalgesia induced by intraplantar carrageenan injections in male and female rats
Figure 3
Figure 3
Effects of intrathecally injected TC OT 39 on thermal hyperalgesia induced by intraplantar carrageenan injections in male and female rats
Figure 4
Figure 4
Effects of the co-administration of atosiban with WAY 267,464 or TC OT 39 on thermal hyperalgesia induced by intraplantar carrageenan injections in male rats
Figure 5
Figure 5
Effects of co-administration of atosiban with WAY 267,464 or TC OT 39 on thermal hyperalgesia induced by intraplantar carrageenan injections in female rats
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Lee HJ, Macbeth AH, Pagani JH, Young WS. Oxytocin: The great facilitator of life. Prog Neurobiol. 2009;88:127–151. - PMC - PubMed
    1. Xin Q, Bai B, Liu W. The analgesic effects of oxytocin in the peripheral and central nervous system. Neurochem Int. 2017;103:57–64. - PubMed
    1. Condes-Lara M, Martinez-Lorenzana G, Rojas-Piloni G, Rodriguez-Jimenez J. Branched oxytocinergic innervations from the paraventricular hypothalamic nuclei to superficial layers in the spinal cord. Brain Res. 2007;1160:20–29. - PubMed
    1. Breton JD, Veinante P, Uhl-Bronner S, Vergnano AM, Freund-Mercier MJ, Schlichter R, et al. Oxytocin-induced antinociception in the spinal cord is mediated by a subpopulation of glutamatergic neurons in lamina I-II, which amplify GABAergic inhibition. Mol Pain. 2008;4:19–31. - PMC - PubMed
    1. Yu SQ, Lundeberg T, Yu LC. Involvement of oxytocin in spinal antinociception in rats with inflammation. Brain Res. 2003;983:13–22. - PubMed